1813.Two
1813.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. 1813.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
1813.TWO operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position. Its liquidity position is marked by a current ratio of 1.13, suggesting a moderate ability to meet short-term obligations. The company's price-to-book ratio of 0.82 implies that the market values the company at a discount to its book value, which may reflect concerns about its profitability or future growth prospects.
Profitability metrics reveal a challenging financial situation. The company reported a net loss of -47.94 million TWD, with a return on equity of -7% and a return on assets of -5.14%. These figures are below the industry median for profitability, indicating that the company is underperforming relative to its peers in terms of generating returns on invested capital and assets.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks, particularly if demand for its products or services declines in its primary market.
Looking ahead, the company's growth trajectory appears uncertain. The financial data does not provide specific outlook figures for the current or next fiscal year, but the negative operating and net income suggest that the company may face challenges in achieving revenue growth. The company's capital expenditure of -10.28 million TWD indicates a reduction in investment in long-term assets, which could impact its ability to expand or modernize its operations.
The risk assessment highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's financial performance and negative cash flows may necessitate future financing activities that could lead to dilution.
Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The financial statements indicate a need for the company to address its profitability and liquidity issues, which may involve cost restructuring, revenue diversification, or other operational improvements.
- The company is operating at a net loss with negative returns on equity and assets, indicating poor profitability.
- The company's liquidity position is moderate, with a current ratio of 1.13, but it has a negative net cash position after debt.
- The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.32.
- The company's growth prospects are uncertain, with no specific outlook figures provided and a reduction in capital expenditures.
- The company's risk profile includes medium liquidity risk and low dilution risk, but it faces challenges in achieving profitability and maintaining liquidity.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 1813.TWO Market data — financials · 2026-05-26